Side by side
Compare compounds
Add up to three compounds with the compare button on any library card or compound page.
Swipe the table sideways to see every compound.
| Attribute |  |
|---|---|
| Category | Metabolic |
| Evidence grade | A Human trial evidence |
| Regulatory status | Investigational |
| Human amounts | Trial dosesDosing reference Study durations |
| Format | Lyophilized vial |
| Type | Single compound |
| Molecular formula | Not listed |
| Molecular weight | Not listed |
| CAS number | Not listed |
| Sequence | Not listed |
| References | 14 |
| Summary | Amycretin (now also called zenagamtide) is an investigational single-molecule peptide that activates both GLP-1 and amylin receptors. It has been studied in subcutaneous and oral forms in phase 1 and phase 2 randomized trials, and phase 3 trials are registered. It is not an approved medicine, and this entry is for research information only. |